DE60103868D1 - N-heterocyclyl-benzen oder -pyridin-sulfonamide zur verwendung als anti-thrombogene und antikoagulierende verbindungen - Google Patents

N-heterocyclyl-benzen oder -pyridin-sulfonamide zur verwendung als anti-thrombogene und antikoagulierende verbindungen

Info

Publication number
DE60103868D1
DE60103868D1 DE60103868T DE60103868T DE60103868D1 DE 60103868 D1 DE60103868 D1 DE 60103868D1 DE 60103868 T DE60103868 T DE 60103868T DE 60103868 T DE60103868 T DE 60103868T DE 60103868 D1 DE60103868 D1 DE 60103868D1
Authority
DE
Germany
Prior art keywords
antikoagulating
thrombogenic
sulphonamide
heterocyclyl
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60103868T
Other languages
English (en)
Other versions
DE60103868T2 (de
Inventor
Jean-Michel Altenburger
Gerard Cremer
Gilbert Lassalle
Mostafa Matrougui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of DE60103868D1 publication Critical patent/DE60103868D1/de
Application granted granted Critical
Publication of DE60103868T2 publication Critical patent/DE60103868T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE60103868T 2000-03-23 2001-03-22 N-heterocyclyl-benzen oder -pyridin-sulfonamide zur verwendung als anti-thrombogene und antikoagulierende verbindungen Expired - Lifetime DE60103868T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0003724A FR2806722B1 (fr) 2000-03-23 2000-03-23 Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique
FR0003724 2000-03-23
PCT/FR2001/000861 WO2001070736A1 (fr) 2000-03-23 2001-03-22 N-(heterocyclyl)benzene-ou pyridine sulfonamides comme agents antithrombotiques et anticoagulantes

Publications (2)

Publication Number Publication Date
DE60103868D1 true DE60103868D1 (de) 2004-07-22
DE60103868T2 DE60103868T2 (de) 2005-06-09

Family

ID=8848428

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60103868T Expired - Lifetime DE60103868T2 (de) 2000-03-23 2001-03-22 N-heterocyclyl-benzen oder -pyridin-sulfonamide zur verwendung als anti-thrombogene und antikoagulierende verbindungen

Country Status (35)

Country Link
US (1) US6680329B2 (de)
EP (1) EP1268469B1 (de)
JP (1) JP2003528098A (de)
KR (1) KR100791693B1 (de)
CN (1) CN1183128C (de)
AR (1) AR029900A1 (de)
AT (1) ATE269325T1 (de)
AU (2) AU2001246617B2 (de)
BG (1) BG65863B1 (de)
BR (1) BR0109385A (de)
CA (1) CA2401637C (de)
DE (1) DE60103868T2 (de)
DK (1) DK1268469T3 (de)
EA (1) EA004986B1 (de)
EE (1) EE05084B1 (de)
ES (1) ES2222358T3 (de)
FR (1) FR2806722B1 (de)
HK (1) HK1051537A1 (de)
HR (1) HRP20020762B1 (de)
HU (1) HUP0300695A2 (de)
IL (2) IL151619A0 (de)
IS (1) IS2304B (de)
ME (1) MEP17408A (de)
MX (1) MXPA02009276A (de)
NO (1) NO324835B1 (de)
PL (1) PL204660B1 (de)
PT (1) PT1268469E (de)
RS (1) RS50370B (de)
SI (1) SI1268469T1 (de)
SK (1) SK286687B6 (de)
TR (1) TR200402343T4 (de)
TW (1) TWI290141B (de)
UA (1) UA71667C2 (de)
WO (1) WO2001070736A1 (de)
ZA (1) ZA200206996B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
DE60329415D1 (de) * 2002-12-06 2009-11-05 Purdue Research Foundation Pyridine zur behandlung von verletztemsäugetiernervengewebe
US7750162B2 (en) 2004-04-19 2010-07-06 Daiso Co., Ltd. Process for preparation of nonnatural amino acid and intermediate thereof
EP1739077A4 (de) * 2004-04-19 2008-04-16 Daiso Co Ltd Verfahren zur herstellung von nicht-natürlichen aminosäuren und zwischenprodukte dafür
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
US8586748B2 (en) * 2008-04-09 2013-11-19 Boehringer Ingelheim International Gmbh 2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10
EP2294051B1 (de) * 2008-05-22 2014-08-13 Boehringer Ingelheim International GmbH Alphasubstituierte n-sulfonylgylcinamid-antagonisten von ccr10, zusammensetzungen damit und verfahren zu ihrer verwendung
ES2569983T3 (es) * 2010-01-28 2016-05-13 The Medicines Company (Leipzig) Gmbh Inhibidores de serinproteasa de tipo tripsina y su preparación y uso
FR2981071B1 (fr) * 2011-10-10 2014-02-07 Centre Nat Rech Scient Synthese versatile et stereospecifique d'acides amines gamma,delta-insatures par la reaction de wittig

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727410B1 (fr) * 1994-11-25 1996-12-20 Synthelabo Chlorures de sulfonyles, leur preparation et leur utilisation comme intermediaires de synthese
FR2728570B1 (fr) * 1994-12-23 1997-04-11 Synthelabo Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
FR2756285B1 (fr) * 1996-11-22 1998-12-18 Synthelabo Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique
FR2756220B1 (fr) * 1996-11-27 1998-12-24 Lorraine Laminage Roue pour vehicule terrestre a moteur
FR2771094B1 (fr) * 1997-11-19 2000-02-04 Synthelabo Derives de piperidine-2-carboxylate, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
JP2003528098A (ja) 2003-09-24
EE200200540A (et) 2004-04-15
ES2222358T3 (es) 2005-02-01
MEP17408A (en) 2010-06-10
HUP0300695A2 (hu) 2003-07-28
WO2001070736A1 (fr) 2001-09-27
EA004986B1 (ru) 2004-10-28
IL151619A0 (en) 2003-04-10
YU67002A (sh) 2005-07-19
AR029900A1 (es) 2003-07-23
IL151619A (en) 2009-05-04
EP1268469A1 (de) 2003-01-02
BR0109385A (pt) 2003-06-03
TR200402343T4 (tr) 2004-12-21
PL364988A1 (en) 2004-12-27
NO20024496D0 (no) 2002-09-19
PL204660B1 (pl) 2010-01-29
FR2806722B1 (fr) 2002-05-17
US20030207920A1 (en) 2003-11-06
UA71667C2 (uk) 2004-12-15
CA2401637A1 (en) 2001-09-27
ATE269325T1 (de) 2004-07-15
BG65863B1 (bg) 2010-03-31
EP1268469B1 (de) 2004-06-16
US6680329B2 (en) 2004-01-20
PT1268469E (pt) 2004-10-29
IS6535A (is) 2002-08-30
SK286687B6 (sk) 2009-03-05
HRP20020762A2 (en) 2003-12-31
KR20020081476A (ko) 2002-10-26
FR2806722A1 (fr) 2001-09-28
HK1051537A1 (en) 2003-08-08
HRP20020762B1 (en) 2005-02-28
NO324835B1 (no) 2007-12-17
DK1268469T3 (da) 2004-10-11
DE60103868T2 (de) 2005-06-09
ZA200206996B (en) 2003-09-01
AU2001246617B2 (en) 2006-03-02
MXPA02009276A (es) 2003-05-23
EA200200838A1 (ru) 2003-04-24
AU4661701A (en) 2001-10-03
CN1426407A (zh) 2003-06-25
TWI290141B (en) 2007-11-21
SI1268469T1 (en) 2004-10-31
CN1183128C (zh) 2005-01-05
IS2304B (is) 2007-10-15
BG107130A (bg) 2003-06-30
SK13512002A3 (sk) 2003-03-04
RS50370B (sr) 2009-11-10
EE05084B1 (et) 2008-10-15
KR100791693B1 (ko) 2008-01-03
CA2401637C (en) 2009-11-10
NO20024496L (no) 2002-11-22

Similar Documents

Publication Publication Date Title
ATE335722T1 (de) Benzoylsulfonamide und sulfonylbenzamidine zur verwendung als antitumor-mittel
ATE277910T1 (de) Urazil verbindungen und deren verwendung
DE60021729D1 (de) Photosensibilisatoren enthaltende antimikrobielle zusammensetzung, gegenstände und verfahren zur verwendung
ATE324053T1 (de) Verfahren und verbindungen zur kontrolle des körpergewichts
ATE380812T1 (de) Stickstoffhaltige, bicyclische heterocyclen zur verwendung als antibakterielle mittel
DE69932397D1 (de) Zusammensetzung zur äusserlichen verwendung
DE60115937D1 (de) Piperidinverbindungen zur verwendung als antiallergika
DE60116838D1 (de) Salicylaldehyd enthaltende Zusammensetzung mit antimikrobielle und duftende Eigenschaften und Verfahren zu ihre Verwendung
DE60205817D1 (de) Verfahren zur Erfassung und Beseitigung des Memory-Effektes
DE60106022D1 (de) Thiophenverbindungen zur verwendung als antikrebsmittel
ATE339440T1 (de) Entzündungshemmende verbindungen und ihre verwendung
ATE331512T1 (de) Verwendung azetidinone-substituierter verbindungen zur behandlung der sitosterolhämie
DE60232893D1 (de) Wirbelimplantat
DE60222006D1 (de) Heterozyklische verbindungen und ihre verwendungen
DE60144013D1 (de) Harzzusammensetzung und verwendung derselben
DE60227120D1 (de) Glukokinase beeinflussende Verbindungen
DE60133921D1 (de) Verwendung von rosuvastatin (zd-4522) zur behandlung von heterozygoter familiärer hypercholesterolämie
DE60018792D1 (de) Heterocyclo-alkylsulfonylpyrazolderivate zur verwendung als anti-imflammatorische oder analgetische verbindungen
DE60233444D1 (de) Teileanbringvorrichtung und teileanbringverfahren
ATE411271T1 (de) Verwendung von ketonen als vorstufen von aktiven verbindungen
DE60103868D1 (de) N-heterocyclyl-benzen oder -pyridin-sulfonamide zur verwendung als anti-thrombogene und antikoagulierende verbindungen
DE60024233D1 (de) Verwendung kationischer Verbindungen
DE50107230D1 (de) Sulfamidothienopyrimidine zur verwendung als phosphodiesterase v-hemmer
DE59906907D1 (de) Phosphororganische verbindungen und ihre verwendung
ATE295844T1 (de) Verbindungen und ihre verwendung als hemmer des glycintransports

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS, PARIS, FR

8364 No opposition during term of opposition